All In Biotech

Drug Trial Radar · NCT07601425

Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Jul 27, 2026

Primary completion

Dec 2027

Study completion Mar 2030

Sponsor

Lead sponsor
Atavistik Bio, IncIndustry
Sponsor type
Industry
First posted
May 22, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluating 3 dosing regimens of ATV-1601. Patients completing Part 1 may participate in the Part 2 open-label extension to receive ATV-1601.

Conditions

  • Hereditary Hemorrhagic Telangiectasia (HHT)
  • Osler Weber Rendu Disease

Interventions

  • ATV-1601Drug

    Administered orally, daily

  • PlaceboDrug

    Administered orally, daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Safety and tolerabilityTime frame: 16 weeks
  2. Part 2: Safety and tolerabilityTime frame: 24 months

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Arizona Pulmonary Specialists

    Phoenix, Arizona · Recruiting

  • University of California, San Diego

    San Diego, California · Recruiting

  • Augusta University Medical Center

    Augusta, Georgia · Recruiting

  • Innovative Hematology

    Indianapolis, Indiana · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Washington University in St. Louis

    St Louis, Missouri · Recruiting

  • University of North Carolina

    Chapel Hill, North Carolina · Recruiting

  • University of Texas Southwestern

    Dallas, Texas · Recruiting

  • University of Utah Health Sciences Center

    Salt Lake City, Utah · Recruiting

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.